Overview

Study To Examine Effect Of CP-866,087 On Consumption And Craving Of Alcohol In Alcohol Dependent Subjects.

Status:
Completed
Trial end date:
2004-12-01
Target enrollment:
Participant gender:
Summary
Test the hypothesis that increasing doses of CP-866,087 will decrease the total number of drinks consumed during a 2 hour acute alcohol consumption assessment and to determine the safety and tolerability of multiple doses of CP-866,087 in alcohol dependent subjects compared to placebo.
Phase:
Phase 2
Details
Lead Sponsor:
Pfizer